RNU6-964P

Across TCGA pan-cancer cohorts, RNU6-964P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-964P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNU6-964P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-964P expression acts as an unfavorable survival marker, although some lineages such as LAML and KIRP show a favorable association.

COAD, OV, and ESCA are the cancer types where RNU6-964P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.654	0.802	<.001	108	view →
OV	OS	Quartile	IV	0.406	0.698	.010	20	view →
ESCA	OS	Tertile	All	0.529	0.750	.003	19	view →
DLBC	OS	Tertile	All	0.054	0.842	<.001	18	view →
ACC	DFS	Tertile	II,III,IV	0.114	0.604	.005	18	view →
LAML	DFS	Median	All	0.606	0.337	.005	18	view →
SKCM	OS	Tertile	All	0.615	0.805	.005	15	view →
READ	DFS	Tertile	All	0.359	0.687	.020	12	view →
KIRP	DFS	Tertile	IV	0.622	0.160	.039	12	view →
UCEC	DFS	Tertile	All	0.336	0.706	.026	12	view →
PAAD	OS	Tertile	All	0.519	0.271	.030	9	view →
LIHC	DFS	Tertile	II,III,IV	0.157	0.436	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-964P–COAD (DFS)

Open the COAD breakdown →